221PReal-life data on the cardiac toxicity of adjuvant fixed-dose subcutaneous trastuzumab in HER2-positive breast cancer
De Sanctis, R, D'Antonio, F, Agostinetto, E, Marinello, A, Masci, G, Zuradelli, M, Losurdo, A, Guiducci, D, Tinterri, C, Testori, A, Gatzemeier, W, Errico, V, Torrisi, R, Santoro, AVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy270.216
Date:
October, 2018
File:
PDF, 77 KB
2018